Protective effect of danhong injection on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Wang, Ying ^a   Gao, Li Na ^a   Cui, Yuan Lu ^a   Jiang, Heng Li ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CASPASE 3; CASPASE 8; CASPASE 9; DANHONG INJECTION; GALACTOSAMINE; GLUTATHIONE TRANSFERASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIVER PROTECTIVE AGENT; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LIVER FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; LIPID LIVER LEVEL; LIPID PEROXIDATION; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE;

EID: 84897529965     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/153902     Document Type: Article

References (36)

1. Auzinger G., Wendon J., Intensive care management of acute liver failure. Current Opinion in Critical Care 2008 14 2 179 188 2-s2.0-41849110983 10.1097/MCC.0b013e3282f6a450 (Pubitemid 351498784)
2. Tuñón M. J., Alvarez M., Culebras J. M., González-Gallego J., An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World Journal of Gastroenterology 2009 15 25 3086 3098 2-s2.0-67651250551 10.3748/wjg.15.3086
3. Leifeld L., Dumoulin F.-L., Purr I., Janberg K., Trautwein C., Wolff M., Manns M. P., Sauerbruch T., Spengler U., Early up-regulation of chemokine expression in fulminant hepatic failure. Journal of Pathology 2003 199 3 335 344 2-s2.0-0037373512 10.1002/path.1298 (Pubitemid 36266856)
4. Diehl A. M., Yin M., Fleckenstein J., Yang S. Q., Lin H. Z., Brenner D. A., Westwick J., Bagby G., Nelson S., Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. American Journal of Physiology 1994 267 4 G552 G561 2-s2.0-0028518860
5. Han C., Li G., Lim K., DeFrances M. C., Gandhi C. R., Wu T., Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure. Journal of Immunology 2008 181 11 8027 8035 2-s2.0-58149277371
6. Deng X., Luyendyk J. P., Ganey P. E., Roth R. A., Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models. Pharmacological Reviews 2009 61 3 262 282 2-s2.0-70349694415 10.1124/pr.109.001727
7. Kim S.-H., Yeong S. K., Sam S. K., Bae K., Tran M. H., Lee S.-M., Anti-apoptotic and hepatoprotective effects of gomisin A on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. Journal of Pharmacological Sciences 2008 106 2 225 233 2-s2.0-40549098089 10.1254/jphs.FP0071738 (Pubitemid 351366341)
8. Wang C.-C., Cheng P.-Y., Peng Y.-J., Wu E. S. C., Wei H.-P., Yen M.-H., Naltrexone protects against lipopolysaccharide/D-galactosamine-induced hepatitis in mice. Journal of Pharmacological Sciences 2008 108 3 239 247 2-s2.0-56649109909 10.1254/jphs.08096FP
9. Wang H., Li Y., Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice. European Journal of Pharmacology 2006 534 1-3 194 201 2-s2.0-33644894450 10.1016/j.ejphar.2005.12. 080 (Pubitemid 43384201)
10. Nakama T., Hirono S., Moriuchi A., Hasuike S., Nagata K., Hori T., Ido A., Hayashi K., Tsubouchi H., Etoposide prevents apoptosis in mouse liver with D-Galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality. Hepatology 2001 33 6 1441 1450 2-s2.0-0034992876 10.1053/jhep.2001.24561 (Pubitemid 32496981)
11. Mignon A., Rouquet N., Fabre M., Martin S., Pagès J. C., Dhainaut J. F., Kahn A., Briand P., Joulin V., LPS challenge in D-galactosamine- sensitized mice accounts for caspase- dependent fulminant hepatitis, not for septic shock. American Journal of Respiratory and Critical Care Medicine 1999 159 4 1308 1315 2-s2.0-0032905202 (Pubitemid 29202572)
12. Wen T., Wu Z.-M., Liu Y., Tan Y.-F., Ren F., Wu H., Upregulation of heme oxygenase-1 with hemin prevents d-galactosamine and lipopolysaccharide-induced acute hepatic injury in rats. Toxicology 2007 237 1-3 184 193 2-s2.0-34447097237 10.1016/j.tox.2007.05.014 (Pubitemid 47031416)
13. Chen Q., Yi D., Xie Y., Yang W., Zhuang Y., Du J., Analysis of clinical use of Danhong injection based on hospital information system. Zhongguo Zhongyao Zazhi 2011 36 20 2817 2820 2-s2.0-84855663510 10.4268/cjcmm20112016
14. He Y., Wan H., Du Y., Bie X., Zhao T., Fu W., Xing P., Protective effect of Danhong injection on cerebral ischemia-reperfusion injury in rats. Journal of Ethnopharmacology 2012 144 2 387 394
15. Sun M., Zhang J.-J., Shan J.-Z., Zhang H., Jin C.-Y., Xu S., Wang Y.-L., Clinical observation of Danhong Injection (herbal TCM product from Radix Salviae miltiorrhizae and Flos Carthami tinctorii) in the treatment of traumatic intracranial hematoma. Phytomedicine 2009 16 8 683 689 2-s2.0-67349249405 10.1016/j.phymed.2009.03.020
16. Tai M.-H., Liu L.-M., Ma R.-Q., Li X., Pang J.-X., Xu J.-P., General pharmacology of Danhong injection. Di Yi Jun Yi Da Xue Xue Bao 2005 25 3 335 338 2-s2.0-39049180163
17. Gao L. N., Cui Y. L., Wang Q. S., Wang S. X., Amelioration of Danhong injection on the lipopolysaccharide-stimulated systemic acute inflammatory reaction via multi-target strategy. Journal of Ethnopharmacology 2013 149 3 772 782
18. Jin Y., Wu Z., Liu X., Wu Y., Near infrared spectroscopy in combination with chemometrics as a process analytical technology (PAT) tool for on-line quantitative monitoring of alcohol precipitation. Journal of Pharmaceutical and Biomedical Analysis 2013 77 32 39 10.1016/j.jpba.2013.01.012
19. Liu X., Wu Z., Yang K., Ding H., Wu Y., Quantitative analysis combined with chromatographic fingerprint for comprehensive evaluation of Danhong injection using HPLC-DAD. Journal of Pharmaceutical and Biomedical Analysis 2013 76 70 74
20. Bao-zhong W., Mao-rong C., Wei-hong Z., Peng-fei D., The toxicological study of Danhong. China Practical Medicine 2008 3 27 29
21. Haga S., Terui K., Zhang H. Q., Enosawa S., Ogawa W., Inoue H., Okuyama T., Takeda K., Akira S., Ogino T., Irani K., Ozaki M., Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. Journal of Clinical Investigation 2003 112 7 989 998 2-s2.0-0242348793 10.1172/JCI200317970 (Pubitemid 38056314)
22. Ying-Wan Y.-W., Wu Y.-L., Feng X.-C., Lian L.-H., Jiang Y.-Z., Nan J.-X., The protective effects of total saponins from Ornithogalum saundersiae (Liliaceae) on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice. Journal of Ethnopharmacology 2010 132 2 450 455 2-s2.0-78049401603 10.1016/j.jep.2010.08.025
23. Wu Y.-L., Lian L.-H., Jiang Y.-Z., Nan J.-X., Hepatoprotective effects of salidroside on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. Journal of Pharmacy and Pharmacology 2009 61 10 1375 1382 2-s2.0-74949116903 10.1211/jpp/61.10.0015
24. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
25. Schmittgen T. D., Livak K. J., Analyzing real-time PCR data by the comparative CT method. Nature Protocols 2008 3 6 1101 1108 2-s2.0-44949231424 10.1038/nprot.2008.73 (Pubitemid 351818697)
26. Zhi X. W., Su X. M., Feng W. Y., Zhang H. M., Effect and mechanism of Danhong injection on isolated mesenteric arterial rings in rats. Zhongguo Zhong Yao Za Zhi 2012 37 17 2607 2611
27. Giannini E. G., Testa R., Savarino V., Liver enzyme alteration: a guide for clinicians. Canadian Medical Association Journal 2005 172 3 367 379 2-s2.0-13444282229 10.1503/cmaj.1040752 (Pubitemid 40208726)
28. Lian L.-H., Wu Y.-L., Wan Y., Li X., Xie W.-X., Nan J.-X., Anti-apoptotic activity of gentiopicroside in d-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure. Chemico-Biological Interactions 2010 188 1 127 133 2-s2.0-77956170862 10.1016/j.cbi.2010.06.004
29. Lian L.-H., Jin X., Wu Y.-L., Cai X. F., Lee J. J., Nan J.-X., Hepatoprotective effects of sedum sarmentosum on D-Galactosamine/ lipopolysaccharide-induced murine fulminant hepatic failure. Journal of Pharmacological Sciences 2010 114 2 147 157 2-s2.0-78349243653 10.1254/jphs.10045FP
30. Wolf A. M., Wolf D., Rumpold H., Ludwiczek S., Enrich B., Gastl G., Weiss G., Tilg H., The kinase inhibitor imatinib mesylate inhibits TNF- α production in vitro and prevents TNF-dependent acute hepatic inflammation. Proceedings of the National Academy of Sciences of the United States of America 2005 102 38 13622 13627 2-s2.0-26444535295 10.1073/pnas.0501758102 (Pubitemid 41420898)
31. Josephs M. D., Fukuzuka K., Solorzano C. C., Edwards C. K. III, Tannahill C. L., Mackay S. L. D., Copeland E. M. III, Moldawer L. L., Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF- α and not by Fas ligand. American Journal of Physiology 2000 278 5 R1196 R1201 2-s2.0-20644439772 (Pubitemid 30366447)
32. Kim S.-J., Kim J.-K., Lee D.-U., Kwak J.-H., Lee S.-M., Genipin protects lipopolysaccharide-induced apoptotic liver damage in d-galactosamine-sensitized mice. European Journal of Pharmacology 2010 635 1-3 188 193 2-s2.0-77952322170 10.1016/j.ejphar.2010.03.007
33. Gong X., Luo F.-L., Zhang L., Li H.-Z., Wu M.-J., Li X.-H., Wang B., Hu N., Wang C.-D., Yang J.-Q., Wan J.-Y., Tetrandrine attenuates lipopolysaccharide-induced fulminant hepatic failure in d-galactosamine- sensitized mice. International Immunopharmacology 2010 10 3 357 363 2-s2.0-76849092004 10.1016/j.intimp.2009.12.010
34. Park J.-H., Kim K.-H., Lee W.-R., Han S.-M., Park K.-K., Protective effect of melittin on inflammation and apoptosis in acute liver failure. Apoptosis 2012 17 1 61 69 2-s2.0-84856709506 10.1007/s10495-011-0659-0
35. Zhang X.-P., Jiang J., Yu Y.-P., Cheng Q.-H., Chen B., Effect of Danshen on apoptosis and NF- B protein expression of the intestinal mucosa of rats with severe acute pancreatitis or obstructive jaundice. Hepatobiliary and Pancreatic Diseases International 2010 9 5 537 546 2-s2.0-78249249626
36. Liu T.-Z., Lee K.-T., Chern C.-L., Cheng J.-T., Stern A., Tsai L.-Y., Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor B. Annals of Clinical and Laboratory Science 2001 31 4 383 390 2-s2.0-0034769630 (Pubitemid 32988663)